TrademarkDir
ONE BREATH TECHNOLOGY
LIVE

Serial Number

87594117

Owner

Alexza Pharmaceuticals, Inc.

Attorney

Christopher J. Maier

First Use Date

Sep 13, 2019

Filing Date

Sep 1, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ONE BREATH TECHNOLOGY Trademark

Serial Number: 87594117 • Registration: 5927121

ONE BREATH TECHNOLOGY is a trademark filed by Alexza Pharmaceuticals, Inc. on September 1, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Alexza Pharmaceuticals, Inc. (17 trademarks)

2091 Stierlin Court
Mountain View, CA 94043

Entity Type: 03

NOVA PNEUMA, INC.

6550 DUMBARTON CIRCLE, SUITE A
FREMONT, CA 94555

Entity Type: 03

Trademark Details

Filing Date

September 1, 2017

Registration Date

December 3, 2019

First Use Anywhere

September 13, 2019

First Use in Commerce

September 13, 2019

Published for Opposition

June 19, 2018

Goods & Services

Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, and gastrointestinal disorders, and analgesics; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and pain

Filing History

TEAS SECTION 8 & 15 RECEIVED
May 29, 2026 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 13, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 3, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 18, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 18, 2024 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 30, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 29, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 28, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 28, 2019 AITU
USE AMENDMENT FILED
Oct 11, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 11, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jun 11, 2019 EX2G
SOU EXTENSION 2 FILED
Jun 11, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2018 EXRA
SOU EXTENSION 1 GRANTED
Dec 27, 2018 EX1G
SOU EXTENSION 1 FILED
Dec 27, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 27, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 14, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 19, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 19, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 17, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 17, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 17, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 17, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2018 CRFA
ASSIGNED TO LIE
Apr 25, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 10, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 10, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 10, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 7, 2017 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 28, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 28, 2017 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2017 NWOS
NEW APPLICATION ENTERED
Sep 5, 2017 NWAP

Related Trademarks

More from this Owner

OBT

OBT

OBT

OBT

OBT

OBT

OBT

OBT

ENGAGE THERAPEUTICS

ENGAGE THERAPEUTICS

ENGAGE THERAPEUTICS

ENGAGE THERAPEUTICS